Provided by Tiger Fintech (Singapore) Pte. Ltd.

TuHURA Biosciences, Inc.

3.85
+1.0537.50%
Post-market: 3.68-0.1700-4.42%19:56 EDT
Volume:1.04M
Turnover:3.69M
Market Cap:162.94M
PE:-15.21
High:3.85
Open:2.88
Low:2.83
Close:2.80
Loading ...

TuHURA Biosciences appoints Craig Tendler to board of directors

TIPRANKS
·
11 Mar

TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors

ACCESS Newswire
·
11 Mar

TuHURA Biosciences, Inc. to Present at the 37th Annual ROTH Conference

ACCESS Newswire
·
10 Mar

TuHURA Biosciences Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
03 Mar

HC Wainwright Initiates TuHURA Biosciences at Buy With $13 Price Target

MT Newswires Live
·
03 Mar

TuHURA Biosciences initiated with a Buy at H.C. Wainwright

TIPRANKS
·
03 Mar

Tuhura Biosciences, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating

THOMSON REUTERS
·
03 Mar

TuHURA Biosciences Inc expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
10 Feb

HURA: Initiating an Immune Response

Zacks Small Cap Research
·
04 Feb

When Will TuHURA Biosciences, Inc. (NASDAQ:HURA) Turn A Profit?

Simply Wall St.
·
20 Jan

When Can We Expect A Profit From TuHURA Biosciences, Inc. (NASDAQ:HURA)?

Simply Wall St.
·
18 Jan

TuHURA Biosciences Initiated at Buy by Rodman & Renshaw

Dow Jones
·
19 Dec 2024

TuHURA Biosciences initiated with a Buy at Rodman & Renshaw

TIPRANKS
·
19 Dec 2024

TuHura Biosciences Agrees to Acquire Kineta in Cash-and-Stock Deal

MT Newswires Live
·
12 Dec 2024

Press Release: TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.

Dow Jones
·
12 Dec 2024

TuHURA Biosciences enters definitive merger agreement to acquire Kineta

TIPRANKS
·
12 Dec 2024